Literature DB >> 12852546

A patch source model for treatment planning of ruthenium ophthalmic applicators.

Melvin A Astrahan1.   

Abstract

Beta-ray emitting Ru-106/Rh-106 ophthalmic applicators have been used for close to 4 decades in the treatment of choroidal melanoma. The form factor of these applicators is a spherically concave silver bowl with an inner radius of curvature between 12 and 14 mm, and a total shell thickness of 1 mm. The radioactive nuclide is deposited in a layer 0.1 mm below the concave surface of the applicator. Calculation of dose distributions for clinical treatment planning purposes is complicated by the concave nature of the distributed source, the asymmetric shape of the active region of some applicators, imperfections in the manufacturing process which can result in an inhomogeneous distribution of activity across the active surface, and absorption and scatter in the 0.1 mm layer of silver which seals and protects the radioactive layer. A semi-empirical method of calculating dose distributions for these applicators is described which is fundamentally compatible with treatment planning systems that use the AAPM TG43 brachytherapy formalism. Dose to water is estimated by summing a "patch source" dose function over a discrete number of overlapping patches uniformly distributed over the active surface of the applicator. The patch source dose function differs conceptually from a point source dose function in that it is intended to represent the macroscopic behavior of a small, disk-like region of the applicator. The patch source dose function includes an anisotropy term to account for angular variation in absorption and scatter as particles traverse the 0.1 mm silver window. It geometrically models the nearfield of a patch with properties akin to both a small disk and infinite plane, and models the farfield as if the patch were a point. This allows a manageable number of discrete patches (300 to 1000) to provide accuracy appropriate for clinical treatment planning. This approach has the advantages of using familiar concepts and data structures, it is computationally quick, and it readily adapts to asymmetric applicator shapes and inhomogeneities in the radionuclide distribution. A method for optimizing the patch source dose function parameters is presented, and the dosimetric calculations are compared with published Monte Carlo calculations and measurements.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12852546     DOI: 10.1118/1.1573971

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  10 in total

1.  Monte Carlo Estimation of Absorbed Dose Distributions Obtained from Heterogeneous 106Ru Eye Plaques.

Authors:  Francisco J Zaragoza; Marion Eichmann; Dirk Flühs; Wolfgang Sauerwein; Lorenzo Brualla
Journal:  Ocul Oncol Pathol       Date:  2017-02-23

2.  Accurate estimation of dose distributions inside an eye irradiated with 106Ru plaques.

Authors:  L Brualla; J Sempau; F J Zaragoza; A Wittig; W Sauerwein
Journal:  Strahlenther Onkol       Date:  2012-11-18       Impact factor: 3.621

3.  Monte Carlo Simulation of the Treatment of Eye Tumors with (106)Ru Plaques: A Study on Maximum Tumor Height and Eccentric Placement.

Authors:  Lorenzo Brualla; Francisco J Zaragoza; Wolfgang Sauerwein
Journal:  Ocul Oncol Pathol       Date:  2014-05-07

4.  Monte Carlo Computation of Dose-Volume Histograms in Structures at Risk of an Eye Irradiated with Heterogeneous Ruthenium-106 Plaques.

Authors:  Francisco J Zaragoza; Marion Eichmann; Dirk Flühs; Beate Timmermann; Lorenzo Brualla
Journal:  Ocul Oncol Pathol       Date:  2020-07-20

5.  Modified Geometry of 106Ru Asymmetric Eye Plaques to Improve Dosimetric Calculations in Ophthalmic Brachytherapy.

Authors:  Héctor Miras; José Antonio Terrón; Alejandro Bertolet; Antonio Leal
Journal:  J Pers Med       Date:  2022-04-29

6.  Monte Carlo Simulation of the Treatment of Uveal Melanoma Using Measured Heterogeneous 106Ru Plaques.

Authors:  Francisco J Zaragoza; Marion Eichmann; Dirk Flühs; Andrea Wittig; Wolfgang Sauerwein; Lorenzo Brualla
Journal:  Ocul Oncol Pathol       Date:  2018-10-15

7.  Gamma irradiation of ocular melanoma and lymphoma cells in the presence of gold nanoparticles: in vitro study.

Authors:  Mozhgan Rezaei Kanavi; Somayeh Asadi; Sahar Balagholi; Fatemeh Alikarami; Hassan Nosrati; Hamid Ahmadieh
Journal:  J Appl Clin Med Phys       Date:  2018-04-29       Impact factor: 2.102

8.  The retina dose-area histogram: a metric for quantitatively comparing rival eye plaque treatment options.

Authors:  Melvin A Astrahan
Journal:  J Contemp Brachytherapy       Date:  2013-03-29

9.  Keeping an eye on the ring: COMS plaque loading optimization for improved dose conformity and homogeneity.

Authors:  Nolan L Gagne; Daniel R Cutright; Mark J Rivard
Journal:  J Contemp Brachytherapy       Date:  2012-09-29

10.  Long-Term Outcomes in Uveal Melanoma After Ruthenium-106 Brachytherapy.

Authors:  Gilda Cennamo; Daniela Montorio; Luca D' Andrea; Antonio Farella; Elide Matano; Mario Giuliano; Raffaele Liuzzi; Maria Angelica Breve; Sabino De Placido; Giovanni Cennamo
Journal:  Front Oncol       Date:  2022-01-03       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.